ANL 14.34 Decreased By ▼ -0.41 (-2.78%)
ASC 13.95 Decreased By ▼ -0.05 (-0.36%)
ASL 15.10 No Change ▼ 0.00 (0%)
BOP 8.52 Decreased By ▼ -0.08 (-0.93%)
BYCO 6.54 Decreased By ▼ -0.15 (-2.24%)
FCCL 18.80 No Change ▼ 0.00 (0%)
FFBL 26.85 Increased By ▲ 0.35 (1.32%)
FFL 11.00 Decreased By ▼ -0.19 (-1.7%)
FNEL 10.51 Decreased By ▼ -0.38 (-3.49%)
GGGL 16.25 Increased By ▲ 0.55 (3.5%)
GGL 31.50 Decreased By ▼ -0.61 (-1.9%)
HUMNL 6.24 Decreased By ▼ -0.11 (-1.73%)
JSCL 16.89 Decreased By ▼ -0.37 (-2.14%)
KAPCO 33.10 Decreased By ▼ -0.15 (-0.45%)
KEL 3.27 Increased By ▲ 0.04 (1.24%)
MDTL 2.27 No Change ▼ 0.00 (0%)
MLCF 37.10 Increased By ▲ 0.65 (1.78%)
NETSOL 102.80 Increased By ▲ 0.64 (0.63%)
PACE 4.68 Increased By ▲ 0.28 (6.36%)
PAEL 23.15 Decreased By ▼ -0.40 (-1.7%)
PIBTL 7.86 Increased By ▲ 0.16 (2.08%)
POWER 7.05 Increased By ▲ 0.29 (4.29%)
PRL 13.66 Decreased By ▼ -0.27 (-1.94%)
PTC 8.90 Decreased By ▼ -0.17 (-1.87%)
SILK 1.31 Decreased By ▼ -0.04 (-2.96%)
SNGP 41.70 Decreased By ▼ -0.10 (-0.24%)
TELE 16.99 Increased By ▲ 0.06 (0.35%)
TRG 87.75 Decreased By ▼ -2.76 (-3.05%)
UNITY 25.35 Increased By ▲ 0.05 (0.2%)
WTL 2.20 Increased By ▲ 0.05 (2.33%)
BR100 4,671 Increased By ▲ 6.15 (0.13%)
BR30 18,834 Increased By ▲ 159.86 (0.86%)
KSE100 45,369 Increased By ▲ 296.76 (0.66%)
KSE30 17,576 Increased By ▲ 146.24 (0.84%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,737
924hr
Pakistan Cases
1,285,254
41424hr
0.98% positivity
Sindh
475,820
Punjab
443,185
Balochistan
33,484
Islamabad
107,722
KPK
180,075
World

Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaign

  • Amid record coronavirus infections and deaths, Moderna has already moved vaccine supplies from its manufacturing plants to warehouses
  • U.S. Army official says trucks will set out today and shipments will start reaching healthcare providers as soon as Monday
20 Dec 2020

(Los Angeles) U.S. distribution of Moderna Inc’s COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday, vastly widening the rollout started last week by Pfizer Inc.

Amid record coronavirus infections and deaths, Moderna has already moved vaccine supplies from its manufacturing plants to warehouses operated by distributor McKesson Corp.

Workers were packing vaccines into containers and loading them on trucks, U.S. Army General Gustave Perna said during a news conference. Trucks will set out on Sunday and shipments will start reaching healthcare providers as soon as Monday, he said.

Doses of vaccine must travel with security guards, including U.S. Marshals, and will be stored in locked refrigerators. U.S. plans call for at-risk groups such as elderly people in nursing homes and medical workers to receive injections first.

The Food and Drug Administration on Friday approved an emergency use authorization for Moderna’s vaccine, the second COVID-19 vaccine to receive approval.

Moderna said a panel of outside advisers to the U.S. Centers for Disease Control and Prevention voted Saturday to recommend its vaccine for use in people aged 18 and older. The Advisory Committee on Immunization Practices panel voted 11-0 in favor of the vaccine.

The jab developed by Pfizer and its German partner BioNTech SE was authorized Dec. 11.

Pharmaceutical services provider Catalent Inc’s facility in Bloomington, Indiana, is filling and packaging vials with Moderna vaccine and handing them to McKesson. The company is shipping them from its facilities including those in Louisville, Kentucky and Memphis, Tennessee, which are close to air hubs for United Parcel Service Inc and FedEx Corp.

Pfizer organized its own distribution system. The U.S. government’s vaccine program, dubbed Operation Warp Speed, is in charge of logistics for Moderna’s distribution under Perna.

Perna apologized to U.S. governors for confusion on the vaccine’s availability after the U.S. government reduced the number of doses states would receive in the upcoming week.

States including Oregon and Washington, which are ramping up to get frontline healthcare workers vaccinated as quickly as possible, said their allocation had dropped by as much as 40%.

Perna said he made an error estimating the number of doses that would actually be cleared by regulators for shipment, which was fewer than the number of doses produced.

A spokeswoman for the U.S. Department of Health and Human Services said 7.9 million doses of Pfizer and Moderna vaccines would be delivered nationally this week.

The Moderna delivery system will have some of the same players as Pfizer’s but will differ in key ways.

Transportation companies UPS and FedEx are giving priority to vaccines on planes and trucks that are moving holiday gifts and other cargo. Their drivers will handle the bulk of the last-mile Moderna vaccine deliveries. They are going directly to vaccination sites, unlike Pfizer’s which was sent to large hubs and redistributed.

“We added a lot of aircraft, a lot of temporary workers. (Vaccines) are a very small fraction of total volumes,” said Wes Wheeler, a UPS executive in charge of vaccine shipments. Moderna’s vaccine is available in quantities as small as 100 doses and can be stored for 30 days in standard-temperature refrigerators, while the inoculations from Pfizer come in boxes of 975 doses, must be shipped and stored at -70 Celsius (-94 F), and can be held for only five days at standard refrigerator temperatures. Initial doses were given to health professionals. Programs by pharmacies Walgreens and CVS to distribute the Pfizer vaccine to long-term care facilities are expected to start on Monday. A CDC advisory panel on Sunday will consider which groups should get vaccinated next.

Perna said the United States is on track to have enough doses of Pfizer and Moderna vaccines by the end of the year to inoculate 20 million people, as the government projected, but deliveries of those doses may continue into first week of January. Healthcare experts forecast it will take well into 2021 for a significant portion of Americans to be inoculated.

Both vaccines were about 95% effective at preventing illness in clinical trials that found no serious safety issues.

We love hearing your feedback, please help us improve by answering these few survey questions

Comments

Comments are closed.